Literature DB >> 22164190

Natural toxins implicated in the development of Parkinson's disease.

Mohamed Salama, Oscar Arias-Carrión.   

Abstract

Experimental models of Parkinson's disease (PD) are of great importance for improving the design of future clinical trials. Various neurotoxic models are available, including 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), paraquat and rotenone. However, no model is considered perfect; each has its own limitations. Based on epidemiological data, a new trend of using environmental toxins in PD modeling seems attractive and has dominated public discussions of the disease etiology. A search for new environmental toxin-based models would improve our knowledge of the pathology of the condition. Here, we discuss some toxins of natural origin (e.g. cycad-derived toxins, epoxomicin, Nocardia asteroides bacteria, Streptomyces venezuelae bacteria, annonacin and DOPAL) that possibly represent a contributory environmental component to PD.

Entities:  

Keywords:  Parkinson’s disease; animal models; natural toxins; therapeutic testing

Year:  2011        PMID: 22164190      PMCID: PMC3229253          DOI: 10.1177/1756285611413004

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  78 in total

Review 1.  Neurogenesis in substantia nigra of parkinsonian brains?

Authors:  Oscar Arias-Carrión; Elizabeth Yamada; Nils Freundlieb; Miriam Djufri; Lukas Maurer; Guido Hermanns; Bastian Ipach; Wei-Hua Chiu; Corinna Steiner; Wolfgang H Oertel; Günter U Höglinger
Journal:  J Neural Transm Suppl       Date:  2009

2.  Environmental neurotoxin-induced progressive model of parkinsonism in rats.

Authors:  Wei-Bin Shen; Kimberly A McDowell; Aubrey A Siebert; Sarah M Clark; Natalie V Dugger; Kimberly M Valentino; H A Jinnah; Carole Sztalryd; Paul S Fishman; Christopher A Shaw; M Samir Jafri; Paul J Yarowsky
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

3.  Moderate degeneration of nigral neurons after repeated but not after single intrastriatal injections of low doses of 6-hydroxydopamine in mice.

Authors:  Franziska Richter; Melanie Hamann; Angelika Richter
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

Review 4.  Cycad seeds and chronic neurologic disease (Cycas species).

Authors:  Donald G Barceloux
Journal:  Dis Mon       Date:  2009-06       Impact factor: 3.800

5.  Monoamine changes in the brain of BALB/c mice following sub-lethal infection with Nocardia asteroides (GUH-2).

Authors:  K Hyland; B L Beaman; P A LeWitt; A J DeMaggio
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 6.  Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress.

Authors:  Ibrahim Abdulwahid Arif; Haseeb Ahmad Khan
Journal:  Toxicol Ind Health       Date:  2010-03       Impact factor: 2.273

7.  [Risk factors for Parkinson disease: an epidemiologic study].

Authors:  Duarte Pereira; Carolina Garrett
Journal:  Acta Med Port       Date:  2010-02-10

Review 8.  Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Authors:  Christopher A Shaw; Günter U Höglinger
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

9.  Toxin-induced and genetic animal models of Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Parkinsons Dis       Date:  2010-12-22

10.  Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration.

Authors:  Kim A Caldwell; Michelle L Tucci; Jafa Armagost; Tyler W Hodges; Jue Chen; Shermeen B Memon; Jeana E Blalock; Susan M DeLeon; Robert H Findlay; Qingmin Ruan; Philip J Webber; David G Standaert; Julie B Olson; Guy A Caldwell
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more
  10 in total

1.  Signaling pathways involved in 1-octen-3-ol-mediated neurotoxicity in Drosophila melanogaster: implication in Parkinson’s disease.

Authors:  Arati A Inamdar; Prakash Masurekar; Muhammad Hossain; Jason R Richardson; Joan W Bennett
Journal:  Neurotox Res       Date:  2014-02       Impact factor: 3.911

2.  FOXRED1 silencing in mice: a possible animal model for Leigh syndrome.

Authors:  Mohamed Salama; Sara El-Desouky; Aziza Alsayed; Mahmoud El-Hussiny; Abdelrahman Moustafa; Yasmeen Taalab; Wael Mohamed
Journal:  Metab Brain Dis       Date:  2018-11-03       Impact factor: 3.584

3.  Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration.

Authors:  Arati A Inamdar; Muhammad M Hossain; Alison I Bernstein; Gary W Miller; Jason R Richardson; Joan Wennstrom Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

4.  The Chemical Molecule B355252 is Neuroprotective in an In Vitro Model of Parkinson's Disease.

Authors:  Nailya S Gliyazova; Gordon C Ibeanu
Journal:  Cell Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.046

Review 5.  Childhood Lead Exposure and Adult Neurodegenerative Disease.

Authors:  Aaron Reuben
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  The Nocardia cyriacigeorgica GUH-2 genome shows ongoing adaptation of an environmental Actinobacteria to a pathogen's lifestyle.

Authors:  Anthony Zoropogui; Petar Pujic; Philippe Normand; Valérie Barbe; Patrick Belli; Arnault Graindorge; David Roche; David Vallenet; Sophie Mangenot; Patrick Boiron; Véronica Rodriguez-Nava; Sebastien Ribun; Yves Richard; Benoit Cournoyer; Didier Blaha
Journal:  BMC Genomics       Date:  2013-04-27       Impact factor: 3.969

7.  Anti-breast Cancer Agents Derived from Plants.

Authors:  Dmitri O Levitsky; Valery M Dembitsky
Journal:  Nat Prod Bioprospect       Date:  2014-12-03

8.  Virulence test using nematodes to prescreen Nocardia species capable of inducing neurodegeneration and behavioral disorders.

Authors:  Claire Bernardin Souibgui; Anthony Zoropogui; Jeremy Voisin; Sebastien Ribun; Valentin Vasselon; Petar Pujic; Veronica Rodriguez-Nava; Patrick Belly; Benoit Cournoyer; Didier Blaha
Journal:  PeerJ       Date:  2017-10-10       Impact factor: 2.984

Review 9.  From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview.

Authors:  Wolf-Dieter Rausch; Feixue Wang; Khaled Radad
Journal:  J Neural Transm (Vienna)       Date:  2022-04-23       Impact factor: 3.850

Review 10.  Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.

Authors:  Leonie M Heger; Rachel M Wise; J Tabitha Hees; Angelika B Harbauer; Lena F Burbulla
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.